Hexagon Capital Partners LLC Ironwood Pharmaceuticals Inc Transaction History

Hexagon Capital Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$8.25 - $11.35 $1,641 - $2,258	-199 Closed	0 $0
Q2 2023 Jul 24, 2023	BUY	$10.1 - $11.6 $595 - $684	59 Added 42.14%	199 $2,000
Q1 2023 Apr 24, 2023	BUY	$10.37 - $12.56 $1,078 - $1,306	104 Added 288.89%	140 $1,000
Q3 2022 Oct 17, 2022	BUY	$10.14 - $12.38 $365 - $445	36 New	36 $0

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Hexagon Capital Partners LLC with notifications on news.